| Year |
Citation |
Score |
| 2022 |
Cheng L, Maboh RN, Wang H, Mao GW, Wu XY, Chen H. Naoxintong capsule activates the Nrf2/HO-1 signaling pathway and suppresses the p38α signaling pathway via estrogen receptors to ameliorate heart remodeling in female mice with postmenopausal hypertension. Journal of Cardiovascular Pharmacology. PMID 35500215 DOI: 10.1097/FJC.0000000000001285 |
0.306 |
|
| 2019 |
Fassett J, Xu X, Kwak D, Zhu G, Fassett EK, Zhang P, Wang H, Mayer B, Bache RJ, Chen Y. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction. Journal of Molecular and Cellular Cardiology. PMID 30910669 DOI: 10.1016/j.yjmcc.2019.03.015 |
0.333 |
|
| 2017 |
Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction. Basic Research in Cardiology. 112: 55. PMID 28819685 DOI: 10.1007/s00395-017-0644-z |
0.313 |
|
| 2014 |
Liu X, Kwak D, Lu Z, Xu X, Fassett J, Wang H, Wei Y, Cavener DR, Hu X, Hall J, Bache RJ, Chen Y. Endoplasmic reticulum stress sensor protein kinase R-like endoplasmic reticulum kinase (PERK) protects against pressure overload-induced heart failure and lung remodeling. Hypertension. 64: 738-44. PMID 24958502 DOI: 10.1161/HYPERTENSIONAHA.114.03811 |
0.317 |
|
| 2014 |
Lu Z, Xu X, Fassett J, Kwak D, Liu X, Hu X, Wang H, Guo H, Xu D, Yan S, McFalls EO, Lu F, Bache RJ, Chen Y. Loss of the eukaryotic initiation factor 2α kinase general control nonderepressible 2 protects mice from pressure overload-induced congestive heart failure without affecting ventricular hypertrophy. Hypertension. 63: 128-35. PMID 24166753 DOI: 10.1161/HYPERTENSIONAHA.113.02313 |
0.305 |
|
| 2013 |
Zhang L, Malik S, Pang J, Wang H, Park KM, Yule DI, Blaxall BC, Smrcka AV. Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell. 153: 216-27. PMID 23540699 DOI: 10.1016/J.Cell.2013.02.047 |
0.712 |
|
| 2007 |
Oestreich EA, Wang H, Malik S, Kaproth-Joslin KA, Blaxall BC, Kelley GG, Dirksen RT, Smrcka AV. Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. The Journal of Biological Chemistry. 282: 5488-95. PMID 17178726 DOI: 10.1074/Jbc.M608495200 |
0.672 |
|
| 2005 |
Wang H, Oestreich EA, Maekawa N, Bullard TA, Vikstrom KL, Dirksen RT, Kelley GG, Blaxall BC, Smrcka AV. Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circulation Research. 97: 1305-13. PMID 16293787 DOI: 10.1161/01.Res.0000196578.15385.Bb |
0.666 |
|
| 2004 |
Ghosh M, Wang H, Kelley GG, Smrcka AV. Purification of phospholipase C beta and phospholipase C epsilon from Sf9 cells. Methods in Molecular Biology (Clifton, N.J.). 237: 55-64. PMID 14501038 DOI: 10.1385/1-59259-430-1:55 |
0.561 |
|
| Show low-probability matches. |